Shanta Dutta Selected Research

Shanta Dutta Research Topics

Disease

28	Infections 04/2024 - 09/2016
23	Typhoid Fever (Typhoid) 12/2023 - 07/2009
19	Cholera 01/2024 - 01/2018
8	Diarrhea 01/2024 - 10/2011
7	Dengue (Dengue Fever) 02/2024 - 01/2019
7	Fever (Fevers) 02/2024 - 12/2006
7	COVID-19 12/2022 - 08/2020
5	Inflammation (Inflammations) 10/2023 - 06/2022
4	Bacillary Dysentery (Shigellosis) 02/2023 - 01/2019
4	Dehydration (Water Stress) 03/2021 - 05/2011
3	Human Influenza (Influenza) 01/2023 - 01/2020
3	Neonatal Sepsis 01/2023 - 01/2021
3	Gastroenteritis 08/2022 - 10/2019
2	Salmonella Infections (Salmonellosis) 11/2023 - 01/2022
2	Sepsis (Septicemia) 01/2023 - 01/2022
2	Communicable Diseases (Infectious Diseases) 10/2021 - 08/2021
2	Coinfection 01/2021 - 11/2006
1	Blood-Borne Infections 02/2024
1	Cross Infection (Nosocomial Infection) 02/2024
1	Amebiasis (Amoebiasis) 01/2024
1	Urinary Tract Infections (Urinary Tract Infection) 01/2024
1	Stomach Neoplasms (Stomach Cancer) 10/2023
1	Giardiasis 10/2023
1	Bacterial Infections (Bacterial Infection) 02/2023
1	Dysbiosis 01/2023
1	Bacteremia 10/2022
1	Intussusception 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Syphilis 01/2022
1	Severe Dengue 01/2022

Drug/Important Bio-Agent (IBA)

28	VaccinesIBA 01/2024 - 07/2009
16	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 12/2013
8	Cholera Vaccines FDA Link 01/2024 - 01/2018
6	Conjugate VaccinesIBA 12/2023 - 01/2018
5	CytokinesIBA 04/2024 - 12/2018
4	Immunoglobulin M (IgM)IBA 10/2022 - 01/2019
4	FluoroquinolonesIBA 12/2021 - 04/2008
3	Carbapenems (Carbapenem Antibiotics)IBA 02/2024 - 01/2021
3	Proteins (Proteins, Gene)FDA Link 10/2023 - 01/2019
3	EnzymesIBA 10/2023 - 01/2022
3	Interleukin-6 (Interleukin 6)IBA 04/2023 - 01/2019
3	AntigensIBA 10/2022 - 01/2019
3	AntibodiesIBA 01/2022 - 01/2021
3	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 12/2021 - 01/2018
3	Azithromycin (Zithromax)FDA LinkGeneric 11/2021 - 07/2016
3	Immunoglobulin G (IgG)IBA 01/2021 - 05/2014
3	SolutionsIBA 08/2020 - 05/2011
3	Typhoid-Paratyphoid Vaccines (Typhoid Vaccines)FDA Link 01/2020 - 05/2014
3	Polysaccharides (Glycans)IBA 01/2020 - 05/2014
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 02/2024 - 10/2022
2	RNA (Ribonucleic Acid)IBA 02/2024 - 11/2006
2	CholesterolIBA 10/2023 - 07/2019
2	Interleukin-10 (Interleukin 10)IBA 04/2023 - 12/2018
2	Interleukin-8 (Interleukin 8)IBA 02/2023 - 01/2019
2	LipopolysaccharidesIBA 01/2022 - 12/2006
2	Cholera ToxinIBA 01/2021 - 01/2020
2	Combined VaccinesIBA 01/2021 - 01/2018
2	ZincIBA 01/2019 - 10/2011
1	Transfer RNA (tRNA)IBA 01/2024
1	Erythromycin (Erycette)FDA LinkGeneric 01/2024
1	shancholIBA 12/2023
1	TCVSIBA 12/2023
1	Coenzyme A (CoA)IBA 10/2023
1	Oxidoreductases (Dehydrogenase)IBA 10/2023
1	Lysophospholipase (Phospholipase B)IBA 10/2023
1	AlarminsIBA 10/2023
1	HMGB1 Protein (HMG1)IBA 10/2023
1	Glycyrrhizic Acid (Glycyrrhizin)IBA 10/2023
1	Butyrates (Butyrate)IBA 04/2023
1	cyclo(Arg-Pro) (CI 4)IBA 03/2023
1	asiatic acidIBA 02/2023
1	Virulence Factors (Pathogenicity Factors)IBA 02/2023
1	F 4 (F-4)IBA 01/2023
1	Oxygen (Dioxygen)IBA 01/2023
1	COVID-19 VaccinesIBA 12/2022
1	EmulsionsIBA 10/2022
1	Fish OilsIBA 10/2022
1	Streptomycin (Streptomycin Sulfate)FDA Link 10/2022
1	fluorescein isothiocyanate dextranIBA 10/2022
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 10/2022
1	NF-kappa B (NF-kB)IBA 06/2022
1	MicroRNAs (MicroRNA)IBA 06/2022
1	Capsaicin (Zostrix)FDA Link 06/2022
1	Ferritins (Ferritin)IBA 01/2022
1	Colistin (Coly-Mycin)FDA Link 01/2022
1	ElementsIBA 01/2022
1	ImmunosorbentsIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	ORALIT (ORS)IBA 12/2021
1	Third Generation CephalosporinsIBA 12/2021
1	Ciprofloxacin (Cipro)FDA LinkGeneric 11/2021
1	DNA (Deoxyribonucleic Acid)IBA 10/2021
1	Nucleic AcidsIBA 10/2021

Therapy/Procedure

8	Therapeutics 01/2022 - 05/2011
2	Fluid Therapy (Oral Rehydration Therapy) 10/2011 - 05/2011
1	Oral Administration 11/2023
1	Phage Therapy 01/2023
1	Personal Protective Equipment 10/2022
1	Prenatal Care (Care, Prenatal) 01/2022
1	Critical Care (Surgical Intensive Care) 12/2021